Abstract

BackgroundZimbabwe’s Ministry of Health and Child Care (MOHCC) adopted 2013 World Health Organization (WHO) prevention of mother-to-child HIV transmission (PMTCT) guidelines recommending initiation of HIV-positive pregnant and breastfeeding women (PPBW) on lifelong antiretroviral treatment (ART) irrespective of clinical stage (Option B+). Option B+ was officially launched in Zimbabwe in November 2013; however the acceptability of life-long ART and its potential uptake among women was not known.MethodsA qualitative study was conducted at selected sites in Harare (urban) and Zvimba (rural) to explore Option B+ acceptability; barriers, and facilitators to ART adherence and service uptake. In-depth interviews (IDIs), focus group discussions (FGDs) and key informant interviews (KIIs) were conducted with PPBW, healthcare providers, and community members. All interviews were audio-recorded, transcribed, and translated; data were coded and analyzed in MaxQDA v10.ResultsForty-three IDIs, 22 FGDs, and five KIIs were conducted. The majority of women accepted lifelong ART. There was however, a fear of commitment to taking lifelong medication because they were afraid of defaulting, especially after cessation of breastfeeding. There was confusion around dosage; and fear of side effects, not having enough food to take drugs, and the lack of opportunities to ask questions in counseling. Participants reported the need for strengthening community sensitization for Option B+. Facilitators included receiving a simplified pill regimen; ability to continue breastfeeding beyond 6 months like HIV-negative women; and partner, community and health worker support. Barriers included distance of health facility, non-disclosure of HIV status, poor male partner support and knowing someone who had negative experience on ART.ConclusionsThis study found that Option B+ is generally accepted among PPBW as a means to strengthen their health and protect their babies. Consistent with previous literature, this study demonstrated the importance of male partner and community support in satisfactory adherence to ART and enhancing counseling techniques. Strengthening community sensitization and male knowledge is critical to encourage women to disclose their HIV status and ensure successful adherence to ART. Targeting and engaging partners of women will remain key determinants to women’s acceptance and adherence on ART under Option B+.

Highlights

  • Zimbabwe’s Ministry of Health and Child Care (MOHCC) adopted 2013 World Health Organization (WHO) prevention of mother-to-child Human immune virus (HIV) transmission (PMTCT) guidelines recommending initiation of HIV-positive pregnant and breastfeeding women (PPBW) on lifelong antiretroviral treatment (ART) irrespective of clinical stage (Option B+)

  • In 2014, an estimated 66,014 pregnant women were in need of antiretroviral therapy (ART) for prevention of mother to child transmission (PMTCT) of HIV [2], while 57,991 (88%) pregnant and lactating women were initiated on antiretroviral therapy (ART) in that year [2]

  • This study found significant proportions of women initiated antiretroviral therapy through Option B+ discontinued it [8]

Read more

Summary

Introduction

Zimbabwe’s Ministry of Health and Child Care (MOHCC) adopted 2013 World Health Organization (WHO) prevention of mother-to-child HIV transmission (PMTCT) guidelines recommending initiation of HIV-positive pregnant and breastfeeding women (PPBW) on lifelong antiretroviral treatment (ART) irrespective of clinical stage (Option B+). According to the 2015 Spectrum modelling national HIV estimates, HIV prevalence among adults 15–49 years in Zimbabwe in 2014 was 14.7% [2] Among those most affected are pregnant women: with an estimated prevalence of 16.7% [2]. The cascade of HIV prevention of mother-to-child transmission (PMTCT) interventions includes antenatal care services, HIV testing during pregnancy, use of antiretroviral therapy (ART) by the woman during pregnancy and the mother and her newborn baby during the breastfeeding period, safe delivery practices, safe infant feeding practices, early HIV testing of the infant and other post-natal healthcare services [3]. Women with a CD4 > 350 cells/ mm, and WHO stages 1 and or 2 were initiated on antiretroviral prophylaxis

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call